NeuroPace Q1 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $18.124M Beat $17.302M Estimate
NeuroPace Q1 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $18.124M Beat $17.302M Estimate
NeuroPace 2024年第一季度GAAP每股收益美元（0.32）超过预期（0.33），销售额为1,8124万美元，超过预期的1730.2万美元
NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.33) by 3.03 percent. This is a 21.95 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $18.124 million which beat the analyst consensus estimate of $17.302 million by 4.75 percent. This is a 25.23 percent increase over sales of $14.472 million the same period last year.
NeuroPace（纳斯达克股票代码：NPCE）公布的季度亏损为每股0.32美元，比分析师普遍预期的0.33美元（0.33美元）高出3.03个百分点。与去年同期每股亏损0.41美元（0.41美元）相比，增长了21.95％。该公司公布的季度销售额为1812.4万美元，比分析师普遍预期的1730.2万美元高出4.75％。这比去年同期的14472万美元的销售额增长了25.23％。